Terns Pharmaceuticals, Inc. (TERN)
NASDAQ·Healthcare·Biotechnology
$52.97
+0.04%
Mkt Cap $4.76B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.29 | -$0.24 | +15.52% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.30 | -$0.27 | +10.00% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$0.28 | -$0.26 | +7.14% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.29 | -$0.26 | +10.34% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.30 | -$0.24 | +20.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.33 | -$0.28 | +15.15% | — | — |
| Q3 2024 Aug 5, 2024 | — | — | — | -$0.35 | -$0.31 | +11.43% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.36 | -$0.30 | +16.67% | — | — |
| Q1 2024 Mar 14, 2024 | — | $1.32M | — | -$0.29 | -$0.29 | +0.00% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.31 | -$0.42 | -35.48% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.32 | -$0.25 | +21.88% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.28 | -$0.31 | -10.71% | — | — |
| Q1 2023 Mar 27, 2023 | — | — | — | -$0.42 | -$0.29 | +30.95% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.51 | -$0.44 | +13.73% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.63 | -$0.55 | +12.70% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.67 | -$0.55 | +17.91% | — | — |
| Q1 2022 Mar 3, 2022 | — | $1.00M | — | -$0.67 | -$0.56 | +16.42% | — | — |
| Q4 2021 Nov 15, 2021 | $2 | — | — | -$0.60 | -$0.47 | +21.67% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.81 | -$0.43 | +46.91% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.53 | -$0.88 | -66.04% | — | — |